Suchergebnisse - "Gerstner, Elizabeth R"

PubPharm (196)

51

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

enthalten in: Neuro-oncology | 2020

von Boxerman, J. | Quarles, C. | Hu, L. | +29

52

Publisher Correction : Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

enthalten in: Nature medicine | 2020

von Brastianos, P. | Lee, E. | Cohen, J. | +29

ErratumFor: Nat Med. 2020 Aug;26(8):1280-1284. - PMID 32483359

53

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

enthalten in: Nature medicine | 2020

von Brastianos, P. | Lee, E. | Cohen, J. | +29

ErratumIn: Nat Med. 2020 Jun 18;:. - PMID 32555425

54

DeepNeuro: an open-source deep learning toolbox for neuroimaging

enthalten in: Neuroinformatics | 2020

von Beers, A. | Brown, J. | Chang, K. | +8

55

DeepNeuro: an open-source deep learning toolbox for neuroimaging

enthalten in: Neuroinformatics | 2020

von Beers, A. | Brown, J. | Chang, K. | +8

56

DeepNeuro: an open-source deep learning toolbox for neuroimaging

enthalten in: Neuroinformatics | 2020

von Beers, A. | Brown, J. | Chang, K. | +8

57

NRG/RTOG 1122 : A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

enthalten in: Cancer | 2020

von Lee, E. | Zhang, P. | Wen, P. | +16

58

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

enthalten in: Nature genetics | 2020

von Shih, D. | Nayyar, N. | Bihun, I. | +40

CommentIn: Cancer Discov. 2020 May;10(5):638. - PMID 32245821

59

A Common Rule for Resection of Glioblastoma in the Molecular Era

enthalten in: JAMA oncology | 2020

von Choi, B. | Gerstner, E. | Curry, W.

CommentOn: JAMA Oncol. 2020 Apr 1;6(4):495-503. - PMID 32027343

60

Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients

enthalten in: Neuro-oncology advances | 2020

von Gerstner, E. | Emblem, K. | Yen, Y. | +10